• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

《暴发性心肌炎患者的静脉-动脉体外膜肺氧合：当代文献回顾》

Veno-Arterial Extracorporeal Membrane Oxygenation in Patients with Fulminant Myocarditis: A Review of Contemporary Literature.

机构信息

Department of Medicine, Barnes-Jewish Hospital, Washington University of Saint Louis, St. Louis, MO 63110, USA.

Respiratory Institute, Cleveland Clinic Foundation, Cleveland, OH 44106, USA.

出版信息

Medicina (Kaunas). 2022 Feb 1;58(2):215. doi: 10.3390/medicina58020215.

DOI:10.3390/medicina58020215
PMID:35208538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8876206/
Abstract

Fulminant myocarditis is characterized by life threatening heart failure presenting as cardiogenic shock requiring inotropic or mechanical circulatory support to maintain tissue perfusion. There are limited data on the role of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in the management of fulminant myocarditis. This review seeks to evaluate the management of fulminant myocarditis with a special emphasis on the role and outcomes with VA-ECMO use.

摘要

暴发性心肌炎的特征是危及生命的心衰，表现为心源性休克，需要正性肌力或机械循环支持来维持组织灌注。关于静脉-动脉体外膜肺氧合（VA-ECMO）在暴发性心肌炎治疗中的作用，数据有限。本综述旨在评估暴发性心肌炎的治疗方法，特别强调 VA-ECMO 使用的作用和结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117c/8876206/da7c053de63c/medicina-58-00215-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117c/8876206/da7c053de63c/medicina-58-00215-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117c/8876206/da7c053de63c/medicina-58-00215-g001.jpg

相似文献

1
Veno-Arterial Extracorporeal Membrane Oxygenation in Patients with Fulminant Myocarditis: A Review of Contemporary Literature.《暴发性心肌炎患者的静脉-动脉体外膜肺氧合：当代文献回顾》
Medicina (Kaunas). 2022 Feb 1;58(2):215. doi: 10.3390/medicina58020215.
2
Acute mechanical circulatory support for fulminant myocarditis complicated by cardiogenic shock.急性机械循环支持治疗暴发性心肌炎并发心源性休克
J Cardiovasc Transl Res. 2014 Mar;7(2):156-64. doi: 10.1007/s12265-013-9521-9. Epub 2014 Jan 14.
3
Short-term use of "ECMELLA" in the context of fulminant eosinophilic myocarditis with cardiogenic shock.在暴发性嗜酸性心肌炎合并心源性休克的情况下短期使用“ECMELLA”。
BMC Cardiovasc Disord. 2020 Dec 10;20(1):519. doi: 10.1186/s12872-020-01808-3.
4
When the heart gets the flu: Fulminant influenza B myocarditis: A case-series report and review of the literature.当心脏染上流感：暴发性乙型流感心肌炎：病例系列报告及文献复习。
J Crit Care. 2018 Oct;47:61-64. doi: 10.1016/j.jcrc.2018.06.001. Epub 2018 Jun 9.
5
Veno-arterial extracorporeal membrane oxygenation for circulatory failure in COVID-19 patients: insights from the ECMOSARS registry.COVID-19 患者循环衰竭的静脉-动脉体外膜肺氧合：来自 ECMOSARS 登记处的见解。
Eur J Cardiothorac Surg. 2023 Sep 7;64(3). doi: 10.1093/ejcts/ezad229.
6
Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors.采用体外膜肺氧合治疗暴发性心肌炎患者的短期死亡率及危险因素的系统评价和荟萃分析。
Heart Fail Rev. 2023 Mar;28(2):347-357. doi: 10.1007/s10741-022-10277-z. Epub 2022 Oct 7.
7
Concomitant use of veno-arterial extracorporeal membrane oxygenation and Impella in the intensive care unit: a case report of fulminant myocarditis with multi-organ failure.重症监护病房中静脉-动脉体外膜肺氧合与Impella的联合应用：暴发性心肌炎合并多器官功能衰竭的病例报告
Anaesthesiol Intensive Ther. 2020;52(1):63-66. doi: 10.5114/ait.2020.93233.
8
Usefulness of extracorporeal membrane oxygenation for treatment of fulminant myocarditis and circulatory collapse.体外膜肺氧合治疗暴发性心肌炎及循环衰竭的有效性
Am J Cardiol. 1998 Oct 1;82(7):910-1. doi: 10.1016/s0002-9149(98)00503-7.
9
[Venoarterial extracorporeal membrane oxygenation: from evidence to clinical practice].[静脉-动脉体外膜肺氧合：从证据到临床实践]
G Ital Cardiol (Rome). 2024 Jun;25(6):410-423. doi: 10.1714/4269.42465.
10
A therapeutic concept to resolve a possible coronary desaturation under Ecpella support and maximize the potential for myocardial recovery: combination of veno-arteriovenous extracorporeal membrane oxygenation and Impella (VAVEcpella).一种可能在 Ecpella 支持下解决冠状低氧血症并最大限度提高心肌恢复潜力的治疗概念：静脉-动脉-静脉体外膜肺氧合和 Impella（VAVEcpella）联合应用。
Perfusion. 2021 Jul;36(5):535-537. doi: 10.1177/0267659120956540. Epub 2020 Sep 15.

引用本文的文献

1
Extracorporeal membrane oxygenation in patient with dilated cardiomyopathy: A case report.扩张型心肌病患者的体外膜肺氧合：病例报告
Int J Surg Case Rep. 2025 May;130:111242. doi: 10.1016/j.ijscr.2025.111242. Epub 2025 Mar 31.
2
Feasibility and Role of Cardiac Magnetic Resonance in Intensive and Acute Cardiovascular Care.心脏磁共振成像在重症及急性心血管护理中的可行性及作用
J Clin Med. 2025 Feb 9;14(4):1112. doi: 10.3390/jcm14041112.
3
Clinical Application of Extracorporeal Membrane Oxygenation in the Treatment of Fulminant Myocarditis.

本文引用的文献

1
Contemporary analysis of charges and mortality in the use of extracorporeal membrane oxygenation: A cautionary tale.体外膜肺氧合使用中费用与死亡率的当代分析：一则警示故事。
JTCVS Open. 2020 Mar 6;1:61-70. doi: 10.1016/j.xjon.2020.02.003. eCollection 2020 Mar.
2
Cardiogenic Shock After Acute Myocardial Infarction: A Review.急性心肌梗死后心原性休克：综述。
JAMA. 2021 Nov 9;326(18):1840-1850. doi: 10.1001/jama.2021.18323.
3
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae.
体外膜肺氧合在暴发性心肌炎治疗中的临床应用
Rev Cardiovasc Med. 2024 Mar 26;25(4):114. doi: 10.31083/j.rcm2504114. eCollection 2024 Apr.
4
Fulminant Myocarditis and Venoarterial Extracorporeal Membrane Oxygenation: A Systematic Review.暴发性心肌炎与静脉-动脉体外膜肺氧合：一项系统评价
Cureus. 2024 Feb 22;16(2):e54711. doi: 10.7759/cureus.54711. eCollection 2024 Feb.
5
Need for a Cardiogenic Shock Team Collaborative-Promoting a Team-Based Model of Care to Improve Outcomes and Identify Best Practices.心源性休克团队协作的必要性——促进基于团队的护理模式，以改善预后并确定最佳实践。
J Am Heart Assoc. 2024 Mar 19;13(6):e031979. doi: 10.1161/JAHA.123.031979. Epub 2024 Mar 8.
6
Emerging concepts in heart failure management and treatment: circulatory support with extracorporeal membrane oxygenation (ECMO).心力衰竭管理与治疗的新观念：体外膜肺氧合（ECMO）循环支持
Drugs Context. 2023 Jan 4;12. doi: 10.7573/dic.2022-7-7. eCollection 2023.
7
Severe COVID-19-associated myocarditis with cardiogenic shock - management with assist devices - a case report & review.严重 COVID-19 相关心肌炎合并心源性休克 - 辅助设备治疗 - 一例报告并复习。
BMC Anesthesiol. 2022 Dec 12;22(1):385. doi: 10.1186/s12871-022-01890-4.
2019冠状病毒病与心力衰竭：从大流行期间的流行病学到心肌损伤、心肌炎及心力衰竭后遗症
Front Cardiovasc Med. 2021 Aug 10;8:713560. doi: 10.3389/fcvm.2021.713560. eCollection 2021.
4
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.米力农与多巴酚丁胺治疗心源性休克的比较。
N Engl J Med. 2021 Aug 5;385(6):516-525. doi: 10.1056/NEJMoa2026845.
5
Myocarditis and Pericarditis After Vaccination for COVID-19.接种 COVID-19 疫苗后的心肌炎和心包炎。
JAMA. 2021 Sep 28;326(12):1210-1212. doi: 10.1001/jama.2021.13443.
6
Cardiopulmonary Resuscitation and Rescue Therapies.心肺复苏与抢救治疗。
Crit Care Med. 2021 Sep 1;49(9):1375-1388. doi: 10.1097/CCM.0000000000005106.
7
Diagnosis and Management of Myocarditis in Children: A Scientific Statement From the American Heart Association.儿童心肌炎的诊断和治疗：美国心脏协会的科学声明。
Circulation. 2021 Aug 10;144(6):e123-e135. doi: 10.1161/CIR.0000000000001001. Epub 2021 Jul 7.
8
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.mRNA COVID-19 疫苗接种后美国军人中的心肌炎。
JAMA Cardiol. 2021 Oct 1;6(10):1202-1206. doi: 10.1001/jamacardio.2021.2833.
9
Efficacy of central extracorporeal life support for patients with fulminant myocarditis and cardiogenic shock.中心体外生命支持对暴发性心肌炎合并心源性休克患者的疗效
Eur J Cardiothorac Surg. 2021 Nov 2;60(5):1184-1192. doi: 10.1093/ejcts/ezab231.
10
Acute heart failure in the course of fulminant myocarditis requiring mechanical circulatory support in a healthy young patient after coronavirus disease 2019.2019冠状病毒病后，一名健康年轻患者暴发性心肌炎病程中出现急性心力衰竭，需要机械循环支持
Kardiol Pol. 2021;79(5):583-584. doi: 10.33963/KP.15888.